课题基金 / 基金详情

Generation of transplantable and gene therapy model rats using IL2 receptor gamma KO rat derived from rat pluripotent stem cell

Generation of transplantable and gene therapy model rats using IL2 receptor gamma KO rat derived from rat pluripotent stem cell
使用源自大鼠多能干细胞的IL2受体γKO大鼠生成可移植和基因治疗模型大鼠
批准号:
23500490
负责人:
HAMANAKA SANAE
金额:
$3.33万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2011
资助国家:
日本
项目状态:
已结题
起止时间:
2011 至 2013

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We generated a model rat of the X-linked serious case combined immunodeficiency disease (X-SCID) by homologous recombination with IL2 receptor gammma gene using rat pluripotent stem cells. T cells, B cells and natural killer cells and the thymus were decreased in the X-SCID rat and it showed the serious case immune deficiency disorder.It was suggested that the X-SCID rat was useful as a model of the cell transplantation of a neoplastic cell of human and mouse hematopoietic stem cells, even though the human hematopoietic stem cells were not able to reconstitution.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1371/journal.pone.0022008
发表时间: 2011
期刊: PloS one
影响因子: 3.7
作者: [Hamanaka S, Yamaguchi T, Kobayashi T, Kato-Itoh M, Yamazaki S, Sato H, Umino A, Wakiyama Y, Arai M, Sanbo M, Hirabayashi M, Nakauchi H]
通讯作者: Nakauchi H
DOI: 10.1073/pnas.1121632109
发表时间: 2012-04-03
期刊: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
影响因子: 11.1
作者: [Ghosn, Eliver Eid Bou, Yamamoto, Ryo, Herzenberg, Leonore A.]
通讯作者: Herzenberg, Leonore A.
DOI: 10.1016/j.bbrc.2013.05.017
发表时间: 2013-06-14
期刊: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
影响因子: 3.1
作者: [Hamanaka, Sanae, Ooehara, Jun, Nakauchi, Hiromitsu]
通讯作者: Nakauchi, Hiromitsu
国内基金
海外基金
间充质干细胞外泌体携带miR-455-3p干预急性移植物抗宿主病的机制研究
探讨小檗碱通过调节肠道菌群改善脂肪酸代谢治疗移植物抗宿主病的机制研究
Masquelet诱导膜技术与游离腓骨瓣移植在胫骨重建中的疗效比较
绝经前乳腺癌患者内分泌治疗相关生殖泌尿系统综合征(GSM)的阴道菌群失调机制及乳杆菌阴道移植的精准干预研究
  • 批准号:
    ZCLHDMY26H1601
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    万芳
  • 依托单位: